Anti-Monopoly Group Targets Healthcare Consolidation to Cut Costs

The analysis, titled 'Break Up Big Medicine,' contends that the current healthcare crisis stems from decades of policy favoring corporate giants. Co-authors Morgan Harper and Emma Freer highlight that six major firms—including UnitedHealth Group and CVS Health—now generate $34 billion in annual profit while employing the vast majority of U.S. doctors. Dr. Will Flanary, an ophthalmologist who contributed to the report, notes that this corporate dominance forces physicians to prioritize administrative tasks like prior authorizations over patient outcomes.

The authors outline a four-part strategy to reclaim $795 billion in annual spending. This includes capping healthcare prices at Medicare reimbursement rates, banning prior authorization requirements, and ending anti-competitive practices like 'spread pricing' used by pharmacy benefit managers. The report arrives as scrutiny intensifies regarding the impact of recent Medicaid cuts and the failure to lower prescription drug costs through existing executive initiatives. While the agenda focuses on antitrust enforcement, it also aligns with broader calls for universal healthcare, as experts like Freer argue that curbing consolidation is a necessary precursor to any successful long-term reform.